AbbVie ABBV
NYSE ABBV
$284.68 -4.39 (-1.52%)
As of: Oct 21, 2026 · 3:59 PM EDT

AbbVie (ABBV) Total Debt (2012 - 2026)

Updated

AbbVie (ABBV) recorded Total Debt of $70.82 billion in Q2 2026, up 0.5% from $70.48 billion a year earlier but down 2.8% from the prior quarter.

Analysis

AbbVie (ABBV) Total Debt (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie reported Total Debt of $67.5 billion, up 0.5% from FY2024.

  • Annual Total Debt has a five-year compound annual growth rate of -4.7% (FY2020 to FY2025).
  • Across earlier years, Total Debt came in at $67.14 billion in FY2024 (+13.1%), $59.39 billion in FY2023 (-6.1%), $63.27 billion in FY2022 (-17.5%) and $76.68 billion in FY2021 (-10.9%).
  • Quarterly Total Debt has ranged from $59.39 billion in Q4 2023 to $80.72 billion in Q3 2021 over the past five years.
  • On a year-over-year basis, Total Debt has increased for three consecutive quarters, with growth averaging 3.3% over the last eight quarters.
  • Peak year-over-year performance for Total Debt in the last five years was growth of 19.2% in Q1 2024, against a decline of 17.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $72.86 billion (Q1 2026), $67.5 billion (Q4 2025) and $68.74 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Vertex Pharmaceuticals 133.33 Bn 105.34 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.82 Bn
Mar 31, 2026 72.86 Bn
Dec 31, 2025 67.50 Bn
Sep 30, 2025 68.74 Bn
Jun 30, 2025 70.48 Bn
Mar 31, 2025 69.89 Bn
Dec 31, 2024 67.14 Bn
Sep 30, 2024 71.08 Bn
Jun 30, 2024 70.63 Bn
Mar 31, 2024 74.00 Bn
Dec 31, 2023 59.39 Bn
Sep 30, 2023 60.75 Bn
Jun 30, 2023 61.02 Bn
Mar 31, 2023 62.09 Bn
Dec 31, 2022 63.27 Bn
Sep 30, 2022 69.61 Bn
Jun 30, 2022 72.93 Bn
Mar 31, 2022 73.47 Bn
Dec 31, 2021 76.68 Bn
Sep 30, 2021 80.72 Bn
API Access

AbbVie Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ABBV&period=max&api_key=YOUR_API_KEY